Stimulation of human platelets with concanavalin A involves phospholipase C activation

Area of Science:

• Biochemistry
• Cell Biology
• Hematology

Background:

• Human platelets play a crucial role in hemostasis and thrombosis.
• Platelet activation involves complex signaling pathways, including calcium mobilization and inositide turnover.

Purpose of the Study:

• To investigate the signaling mechanisms by which concanavalin A activates human platelets.
• To elucidate the role of calcium, phospholipase C, and specific protein interactions in concanavalin A-induced platelet activation.

Main Methods:

• Measurement of cytoplasmic calcium movement in human platelets.
• Assay of inositide turnover and inositol phosphate production.
• Inhibition studies using GDP beta S, cytochalasin B, leupeptin, and amiloride.

Main Results:

• Concanavalin A induced cytoplasmic calcium movement and activated phospholipase C, indicated by increased inositide turnover.
• The activation pathway was independent of GTP-binding transducers, as shown by resistance to GDP beta S.
• Cytochalasin B suggested a role for membrane glycoprotein IIb-IIIa-cytoskeleton interaction.
• Leupeptin and amiloride suggested involvement of Ca(2+)-proteases and Na+/H+ antiport.

Conclusions:

• Concanavalin A activates human platelets via a pathway involving phospholipase C, calcium signaling, and glycoprotein IIb-IIIa-cytoskeleton interactions.
• The signaling mechanism does not rely on canonical GTP-binding protein transduction pathways.
• Ca(2+)-proteases and Na+/H+ antiport may also contribute to concanavalin A-induced platelet activation.